Study Examines Potential Impact Of PEPFAR Funding On TB Incidence, Mortality

The Center for Global Health Policy’s “Science Speaks” blog reports on a study published last week in the Journal of Infectious Diseases that compared data from 12 PEPFAR focus countries with data from 29 control countries to examine the potential impact of PEPFAR funding on the tuberculosis (TB) epidemic in sub-Saharan Africa. The researchers compared TB incidence and mortality rates from periods before and after PEPFAR implementation, and they found both have fallen significantly and to a higher degree in PEPFAR focus countries, the blog notes. “The results, [the researchers] say, point to the need for in-country scrutiny of access to antiretroviral medicines, the ‘three I’s’ of intensified case finding, isoniazid preventive therapy, and infection control of TB-HIV responses, as well as other efforts,” the blog notes (Barton, 8/9).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.